{"disease":{"id":"nintedanib","name":"nintedanib"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04338802","title":"Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":96,"lead_sponsor_name":"Huilan Zhang","has_results":false},{"nct_id":"NCT06570317","title":"Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Second Hospital of Shanxi Medical University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}